Mesenchymal stem cells expressing interleukin-18 inhibit breast cancer in a mouse model

Development of an improved breast cancer therapy has been an elusive goal of cancer gene therapy for a long period of time. Human mesenchymal stem cells derived from umbilical cord (hUMSCs) genetically modified with the interleukin (IL)-18 gene (hUMSCs/IL-18) were previously demonstrated to be able...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoyi, Hu, Jianxia, Li, Yueyun, Cao, Weihong, Wang, Yu, Ma, Zhongliang, Li, Funian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920279/
https://www.ncbi.nlm.nih.gov/pubmed/29725393
http://dx.doi.org/10.3892/ol.2018.8166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920279/
https://www.ncbi.nlm.nih.gov/pubmed/29725393
http://dx.doi.org/10.3892/ol.2018.8166

Ejemplares similares